Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106543017B reveals a mild hydrogenation process for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Novel atmospheric pressure hydrogenation route for S 16257-2 eliminates column chromatography, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN1761644A details scalable synthesis of 4-amino-2-butenoyl chloride for kinase inhibitors. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN102516329B details a safer Gastrodin synthesis using phase-transfer catalysis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115948357A reveals novel ketoreductase mutants for eslicarbazepine production, offering superior stereoselectivity and cost-effective biocatalytic manufacturing solutions.
Novel solid-phase synthesis for peptide derivatives ensures high optical purity and yield, offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Novel patent CN119504565A offers high-purity synthesis route. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Novel Perkin reaction route for CA1 synthesis offers high cis-selectivity and industrial scalability for pharmaceutical intermediates ensuring reliable supply chain.
Novel polycarboxyl BODIPY derivative for photodynamic therapy. High yield, scalable synthesis route reducing manufacturing costs for anticancer applications.
Patent CN101723892B reveals LTA catalysis for high-purity pharmaceutical intermediates. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel patent CN119504447A details high-purity Bromhexine Hydrochloride synthesis avoiding expensive amines ensuring supply chain stability and cost efficiency for pharmaceutical manufacturers globally.
Novel synthesis route for pyrrole-piperidine scaffolds offers significant cost reduction and enhanced supply chain reliability for pharmaceutical intermediates manufacturing globally for drug discovery.
Patent CN1067044C details a robust route for tricyclic colchicine intermediates offering improved regioselectivity and scalable Lewis acid cyclization for pharmaceutical manufacturing.
Patent CN110615751A reveals a safer 2-oxothiopropionamide synthesis route. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN103113291A reveals a high-yield rhodium-catalyzed C-H activation route for 3-alkenylpyridines, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel cyanide-free route for Apalutamide API intermediates. Reduces toxicity, improves purity over 99.5%, ensures supply chain stability for prostate cancer treatments.
Explore CN1262540C technology for non-steroidal AR and PR modulators. Enhanced stability and specificity for pharmaceutical intermediate manufacturing and scale-up.
Patent CN105237473B reveals a metal-free route for high-purity aminonicotinonitrile derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110590658A reveals a novel manganese catalyst for hydrogenation, offering cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Novel synthesis of spiro-indolizine derivatives via 1,3-dipolar cycloaddition. Offers high purity and scalable supply chain solutions for pharmaceutical intermediates.